NLM Logo

cabotegravir MeSH Supplementary Concept Data 2023


MeSH Supplementary
cabotegravir
Unique ID
C584914
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C584914
Entry Term(s)
(3S,11aR)-N-((2,6-difluoropyridin-3-yl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide
Apretude
GSK-1265744
GSK-1265744A
GSK-1265744B
GSK1265744
GSK1265744A
GSK1265744B
GSK744
N-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide
S-265744
S-265744B
Vocabria
cabotegravir extended-release injectable suspension
cabotegravir sodium
sodium (3S,11aR)-8-(((2,4-difluorophenyl)methyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo(3,2-a)pyrido(1,2-d)pyrazin-6-olate
Pharm Action
HIV Integrase Inhibitors
Registry Number
HMH0132Z1Q
Related Numbers
3L12PT535M
Heading Mapped to
*Pyridones
*Diketopiperazines
Frequency
154
Note
an HIV integrase strand transfer inhibitor
Source
HIV Clin Trials. 2013 Sep-Oct;14(5):192-203
Date of Entry
2013/12/12
Revision Date
2022/01/07
cabotegravir Preferred
cabotegravir sodium Narrower
cabotegravir extended-release injectable suspension Narrower
GSK1265744 Narrower
N-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide Broader
page delivered in 0.003s